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Abstract
Type II hexokinase is overexpressed in most neoplastic cells, and it mainly localizes on the outer mitochondrial membrane.
Hexokinase II dissociation from mitochondria triggers apoptosis. The prevailing model postulates that hexokinase II
release from its mitochondrial interactor, the voltage-dependent anion channel, prompts outer mitochondrial membrane
permeabilization and the ensuing release of apoptogenic proteins, and that these events are inhibited by growth factor
signalling. Here we show that a hexokinase II N-terminal peptide selectively detaches hexokinase II from mitochondria and
activates apoptosis. These events are abrogated by inhibiting two established permeability transition pore modulators,
the adenine nucleotide translocator or cyclophilin D, or in cyclophilin D knock-out cells. Conversely, insulin stimulation or
genetic ablation of the voltage-dependent anion channel do not affect cell death induction by the hexokinase II peptide.
Therefore, hexokinase II detachment from mitochondria transduces a permeability transition pore opening signal that
results in cell death and does not require the voltage-dependent anion channel. These findings have profound
implications for our understanding of the pathways of outer mitochondrial membrane permeabilization and their
inactivation in tumors.
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Introduction
Hexokinase (HK) initiates all major pathways of intracellular
glucose utilization, and type II HK (HK II) couples glycolysis to
oxidative phosphorylation by interacting with mitochondria, thus
acting as a metabolic sensor [1]. In highly glycolytic, i.e. extremely
aggressive tumours, mitochondrial HK II activity is increased [2]
and fosters cell growth in the hypoxic conditions of neoplastic mass
accrual by enhancing glycolysis, which becomes independent of
oxygen availability (the Warburg effect, 3). Furthermore, mito-
chondrial HK II plays an important role in maintaining the
integrity of the outer mitochondrial membrane (OMM), thus
preventing the release of key apoptogenic molecules from the
intermembrane space [2]. Reports indicate that nutrients, via the
survival kinase Akt [4,5], promote HK II binding to the voltage-
dependent anion channel [VDAC, 6,7], a protein that allows for
the movement of small metabolites across the OMM [8,9].
Release of HK II transmits a potent death signal [10] that is
elicited when GSK3b, a kinase inhibited by Akt, phosphorylates a
putative HK docking site on VDAC [11]. However, the role of this
pathway remains controversial, as it has been documented that
inhibition of GSK-3b results in GSK-3b-mediated resistance to
oxidant stress [12].
When associated to HK II, VDAC interacts with antiapoptotic
Bcl-2 family members [13]. These might be competed away from
VDAC by the pro-apoptotic Bax/Bak proteins after deprivation of
growth factors, leading to the formation of a conduit on the OMM
fit for the release of apoptogenic proteins [4,14]. Alternatively, the
HK/VDAC interaction could transmit molecular changes to
proteins of the inner mitochondrial membrane (IMM), resulting in
permeability transition pore (PTP) regulation (reviewed in 2). The
PTP is an IMM channel whose opening elicits depolarization,
matrix swelling, and consequently cristae unfolding and breaches
in the OMM that are pervious to proteins [15,16].
A distinction between these two possible scenarios would have
important consequences both on the comprehension of apoptosis
dysregulation in tumors and on the design of therapeutic approaches
targeted to selectively eliminate neoplastic cells. Here, we show that
cell death mediated by HK detachment from mitochondria is
selectively sensitive to modulators of the PTP. Moreover, we
demonstrate that VDAC is dispensable for carrying out this process.
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Clotrimazole detaches HK II from mitochondria but
displays non-specific effects
We initially induced HK II detachment from the OMM with
clotrimazole, a drug that efficiently dissociates HK from
mitochondria in several cell models [e.g. 4,14,17]. As expected,
clotrimazole detached HK II from mitochondria of HeLa cells
(Figure 1A) and of human T lymphoma Jurkat cells (data
not shown). Consistent with published reports, this treatment
prompted a marked and concentration-dependent cell death
(Figure 1B, upper row).
We asked whether HK II detachment from the OMM could
induce cell death by opening the mitochondrial PTP. The
molecular composition of the PTP is at present unsolved.
Nonetheless, pharmacological and genetic evidences identify
cyclophilin (CyP-D), a matrix peptidyl-prolyl cis-trans isomerase,
and the adenine nucleotide translocator (ANT), a carrier that
exchanges adenine nucleotides across the IMM, as pore regulators
[18–22]. Therefore, cells were pretreated with the cyclophilin
inhibitor MeAla3EtVal4-cyclosporin (Debio 025), selectively
targeting CyP-D in mitochondria, and thereby desensitizing the
mitochondrial PTP without inhibiting calcineurin [23,24]. Re-
markably, cell death was fully abrogated (Figure 1B, lower row).
We then directly assessed occurrence of PTP opening by
measuring the threshold Ca
2+ required to open the PTP with
the sensitive Ca
2+ retention capacity (CRC) test. Permeabilized
whole-cells were triggered with trains of Ca
2+ pulses in the
presence of a Ca
2+-sensitive fluorescent probe that does not
permeate mitochondria (see Methods). Ca
2+ uptake into mito-
chondria was therefore displayed as a rapid fluorescence drop.
When the PTP opened, the ensuing Ca
2+ release from
mitochondria was assessed as a sudden fluorescence increase.
We found that clotrimazole inhibited Ca
2+ uptake into mitochon-
dria, i.e. the slope of the fluorescence reduction after each pulse
(Figure 1C), and this same effect was also observed in isolated
mitochondria (not shown). We also found that clotrimazole
dramatically decreased ADP- and uncoupler-stimulated respira-
tion in a concentration-dependent manner (Figure 1D); similar
results were obtained if succinate (in the presence of rotenone)
rather than glutamate/malate was used as a substrate (not shown).
Note that respiration and mitochondrial CRC experiments were
performed in organelles from liver, and hepatocytes have virtually
no HK II [2]. Thus, clotrimazole inhibited respiration by binding
to a molecular target other than HK II, and it appears to be toxic
to mitochondria independently of its activity on HK II and/or
PTP. As dissecting the pharmacology of clotrimazole was beyond
the scope of this study, we achieved HK II detachment from
mitochondria with a different strategy.
A HK II peptide specifically detaches HK II from
mitochondria and induces cell death
Peptides corresponding to the N-terminal hydrophobic domain
of HK were shown to effectively displace it from VDAC [4,14],
suggesting that the latter is required for HK binding to
mitochondria [2,25,26]. We reasoned that this approach could
avoid the unspecific toxic effects observed with clotrimazole. The
commercially available fusion protein Antennapedia-HK II [14]
was not suitable for our experiments since it has been recently
demonstrated that the internalization domain of the Antennapedia
homeoprotein itself exhibits confounding effects on the mitochon-
drial permeability transition ROS threshold in cardiac myocytes
[27]. We therefore linked the N-terminal 15 amino acids of HK II
to a HIV-1 TAT sequence to allow its entry into the cell.
Treatment of HeLa cells with this oligopeptide, called TAT-HK,
efficiently displaced HK II from mitochondria (Figure 2A), and
induced cytochrome c (cyt c) release into the cytosol (Figure 2A), a
hallmark of mitochondrial apoptosis. TAT-HK also disrupted the
interaction between HK II and its reported binding partner on the
OMM, VDAC (Figure 2B). However, in keeping with a previous
work in which cyclosporin A was used [17], we found that the HK
II/VDAC binding could also be abrogated by Debio 025,
irrespective of the presence of the TAT-HK peptide (Figure 2B).
We excluded the possibility that this effect of Debio 025 was due to
inhibition of cytosolic CyP-A, as this protein was not detectable in
our mitochondrial preparations (not shown). TAT-HK caused a
concentration-dependent apoptosis, whereas a peptide obtained by
linking an unrelated sequence to the same TAT motif was totally
ineffective (Figure 2C, upper row). Debio 025 abrogated TAT-
HK-induced apoptosis (Figure 2C, lower row), indicating that this
apoptosis was dependent on PTP opening. Moreover, this
treatment elicited PTP opening in permeabilized HeLa cells, as
assessed by the reduction of the number of Ca
2+ pulses in CRC
assays, without affecting the rate of Ca
2+ uptake into mitochondria
(Figure 2D). To extend these results, the activity of the PTP was
assessed in a model of excitable cells with high metabolic demand
expressing mostly HK II, i.e. freshly isolated adult rat cardiac
myocytes [28]. We previously developed a method that allows
precise determination of the PTP sensitivity to oxidant stress in
intact cardiac myocytes [29]. These cells turned out to be
extremely sensitive to the toxic effect of the peptide. TAT-HK
showed a concentration-dependent effect on the ROS threshold
for mitochondrial permeability transition (MPT) induction (tMPT).
tMPT was significantly decreased in myocytes exposed to .0.1 mM
TAT-HK for 1 hr, and 10 mM TAT-HK induced fast collapse of
the mitochondrial membrane potential followed by cell death
(Figure 2E and data not shown). The control peptide had no effect
over the concentration range tested (up to10 mM).
Unlike clotrimazole, the HK peptide did not affect mitochon-
drial respiration, as measured on isolated mitochondria (Figure 2F).
The PTP modulators CyP-D and ANT are involved in TAT-
HK-elicited apoptosis
In order to further characterize the molecular events deter-
mined by HK displacement from the OMM, we investigated the
role of CyP-D, the mitochondrial target of Debio 025. We carried
out these studies in immortalized fibroblasts from either wild-type
or CyP-D knock-out mice [19] which both express HK II (data not
shown). TAT-HK induced cell death in wild-type fibroblasts, and
this was fully inhibited either by Debio 025 or by the pan-caspase
inhibitor Z.VAD-fmk (Figure 3A). Notably, the peptide was only a
weak apoptosis inducer in cells derived from CyP-D knock-out
mice, and its limited effect was insensitive to Debio 025 but still
inhibitable by Z.VAD-fmk (Figure 3B). The unrelated TAT-linked
peptide was again ineffective (data not shown). The mandatory
role of CyP-D in apoptosis triggered by HK II detachment was
confirmed by direct assessment of pore regulation. In fact,
mitochondria obtained from wild-type muscles, which express
high levels of HK II bound onto their surface, were highly sensitive
to pore opening induced by the peptide in a Debio 025-inhibitable
fashion (Figure 4A), whereas PTP opening was not susceptible to
the HK II peptide in organelles originated from CyP-D knock-out
muscles (Figure 4B). Furthermore, the peptide was completely
unable to sensitize the pore in wild-type mitochondria obtained
from liver (Figure 4C), in which the HK II level is negligible.
These observations consistently indicate that CyP-D plays an
important role in PTP opening and apoptosis induction due to
selective HK II detachment from mitochondria.
HK Release from Mitochondria
PLoS ONE | www.plosone.org 2 March 2008 | Volume 3 | Issue 3 | e1852Figure 1. Effects of clotrimazole on cells and mitochondria. (A) HK II detachment from mitochondria following a 1 hour treatment with
clotrimazole (CTM, 20 mM) was assessed by Western immunoblot on a mitochondrial fraction of HeLa cells. The blot was also probed with prohibitin
as a mitochondrial marker and with actin as a cytosolic marker (negative, not shown), to check for fraction purity. (B) Output of multiparametric FACS
analysis show apoptosis induction of HeLa cells exposed for 2 hours to several concentrations of CTM with or without pre-incubation with Debio 025
(DB, 8 mM). Healthy cells (H) are delimited by the quadrant. Apoptotic cells (A) display mitochondrial depolarization (reduced TMRM staining) and/or
expose phosphatidylserine on their surface (increased Annexin V-FITC staining). Propidium iodide-positive, i.e. dead cells (D), were evaluated on a PI
vs TMRM diagram (not shown); these cells were excluded from the reported plots and shown as histograms. Numbers are percentages. (C) PTP
opening of digitonized HeLa cells measured with the Ca
2+ retention capacity assay. Calcium Green-5N fluorescence is reported as arbitrary units on
the y axis. As the probe does not permeate mitochondria, Ca
2+ uptake into the organelles is displayed by a rapid decrease of the fluorescence spike.
Pore inducers or inhibitors reduce or increase, respectively, the threshold Ca
2+ concentration required to trigger the permeability transition, i.e. the
number of spikes before a sudden and marked fluorescence increase occurs. Experiments were started by the addition of digitonized cells (not
shown) followed by pulses of the indicated concentrations of Ca
2+. Where indicated, CTM was added to cells 45 minutes before permeabilization
with digitonin. Note that CTM reduced the rate of Ca
2+ uptake into mitochondria. In the upper right plot DB was added before mitochondria to test
the PTP-dependence of Ca
2+ release. (D) Respiration assay performed on mitochondria isolated from mouse liver. The graph shows the rate of oxygen
consumption (ng AtO stands for ngatoms of oxygen) vs. different concentrations of CTM. The rate of respiration is displayed in basal conditions (&),
after ADP administration (N) or after dinitrophenol administration (m). All reported results in the Figure are representative of at least four experiments.
doi:10.1371/journal.pone.0001852.g001
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PLoS ONE | www.plosone.org 3 March 2008 | Volume 3 | Issue 3 | e1852Figure 2. Selective detachment of HK II from mitochondria induces PTP opening and cell death. (A) HK II detachment from mitochondria
of HeLa cells following a 1-hour treatment with TAT-HK (20 mM). Western immunoblots of a mitochondrial and of a cytosolic fraction show a
redistribution of both HK II and cytochrome c into the cytosol. Blots were also probed with prohibitin as a mitochondrial marker and with actin as a
cytosolic marker to check for fraction purity. (B) HK II immunoprecipitation in HeLa cells kept in control conditions or treated for 1 hour with Debio
025 (DB, 8 mM), TAT-HK (20 mM), or both. Co-immunoprecipitation of VDAC is shown. (C) Output of multiparametric FACS analyses show apoptosis
induction of HeLa cells exposed for 2 hours to a control peptide linked to the TAT sequence (TAT-Ctr, 40 mM) or to the reported concentrations of
TAT-HK with or without pre-incubation with Debio 025 (DB, 8 mM). Diagrams and percentages of the different cell populations are as in Fig. 1B. (D)
PTP opening of digitonized HeLa cells measured with the Ca
2+ retention capacity assay. Experiments were started by the addition of cells (not shown)
followed by pulses of the indicated concentrations of Ca
2+; where indicated, TAT-HK (30 mM) was added to cells 45 minutes before permeabilization
HK Release from Mitochondria
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mitochondria elicited apoptosis by affecting other pore regulators.
Pharmacological ligands of the IMM protein ANT modulate PTP
opening, but this effect is lost in mitochondria obtained from
ANT knock-out cells. As these mitochondria still undergo the
permeability transition [22], ANT is dispensable as a pore
component, but it operates as a PTP regulator. In this framework,
we reasoned that ANT could funnel a conformational change
from HK II on the mitochondrial surface to modulate the pore in
the inner membrane. In keeping with the presence of a signal
with digitonin. TAT-Ctr (40 mM) did not change the number of Ca
2+ pulses (not shown). Calcium Green-5N fluorescence is reported as arbitrary units
on the y axis. (E) MPT susceptibility to ROS (tMPT) in intact cardiac myocytes is significantly enhanced by TAT-HK while the negative control peptide
TAT-Ctr has no effect. tMPT measurements were performed after 1 hr treatment with peptides. Figure represents four independent experiments with
50–60 cells per groups examined. (F) Respiration assay performed on mouse liver mitochondria. The rate of oxygen consumption (ng AtO stands for
ngatoms of oxygen) is plotted vs. different concentrations of the HK peptide. The rate of respiration is displayed in basal conditions (&), after ADP
administration (N) or after dinitrophenol administration (m). All reported measures in the Figure are representative of at least four experiments.
doi:10.1371/journal.pone.0001852.g002
Figure 3. CyP-D modulates apoptosis triggered by detachment of HK II from mitochondria. (A, B) Output of multiparametric FACS
analyses show apoptosis induction in fibroblasts obtained either from wild-type mice (A) or from mice in which the Ppif gene encoding for CyP-D was
ablated (B). Cells were exposed for 2 hours to the reported concentrations of TAT-HK with or without pre-incubation with Debio 025 (DB, 8 mM) or
with a pan-caspase inhibitor (Z.VAD-fmk, 50 mM). Diagrams and percentages of the different cell populations are indicated as in Fig. 1B. All reported
measures in the Figure are representative of at least four experiments.
doi:10.1371/journal.pone.0001852.g003
HK Release from Mitochondria
PLoS ONE | www.plosone.org 5 March 2008 | Volume 3 | Issue 3 | e1852Figure 4. CyP-D modulates PTP opening triggered by detachment of HK II from mitochondria. CRC experiments were performed on
mitochondria isolated from muscle of either wild-type (A) or CyP-D knock-out mice (B), or from liver of wild-type animals (C). Assays were started by the
addition of mitochondria followed by pulses of the indicated concentrations of Ca
2+; where indicated, the reported concentrations of the HK peptide
lacking the TAT sequence and/or Debio 025 (DB, 8 mM) were added to mitochondria 5 minutes before recordings. Calcium Green-5N fluorescence is
reported as arbitrary units on the y axis. Total Ca
2+ loading required to open the pore is reported for each condition, and all reported results are
representative of at least four experiments. Treatment of mitochondria with the control peptide (40 mM) or with a HK peptide harbouring the TAT
sequence did not change the number of Ca
2+ pulses (not shown). All reported measures in the Figure are representative of at least four experiments.
doi:10.1371/journal.pone.0001852.g004
HK Release from Mitochondria
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observed through immunoprecipitation experiments that the
expected [30] interaction between ANT and CyP-D was
disrupted by the TAT-HK peptide (Figure 5A). Remarkably
bongkrekate, an ANT ligand that stabilizes it in the ‘‘m’’
conformation and acts as an inhibitor of the PTP [31], abrogated
cell death triggered by TAT-HK in wild-type but not in CyP-D-
knock-out cells (Figure 5B). The lethal effect of TAT-HK could
not be rescued by the FOF1 ATP synthase inhibitor oligomycin,
suggesting that the effect of bongkrekate is not secondary to
inhibition of ATP synthesis (data not shown).
VDAC is dispensable for TAT-HK-elicited apoptosis
Following the current model, VDAC phosphorylation by
GSK3b prompts HK II detachment from VDAC and induces
apoptosis. This is inhibited by growth factors through Akt-
dependent inactivation of GSK3b. We therefore stimulated HeLa
cells with insulin, a powerful Akt inducer, to test whether this could
inhibit peptide-mediated apoptosis. Surprisingly, we found that
insulin did not affect TAT-HK elicited apoptosis (Figure 6A).
To formally clarify whether VDAC is essential for the PTP-
opening signal conveyed by HK II displacement, we exploited cells
obtained from VDAC knock-out animals. Three distinct VDAC
isoforms exist in mammals [9]. We utilized mouse embryo
fibroblasts (MEF) obtained from VDAC1/3 knock-out animals
(Figure 6B), as triple knock-out mice are not viable [32]. According
to reports indicating that HK binding is a specific feature of the
VDAC1 isozyme [33], we could not detect any co-immunopre-
cipitation between the residual VDAC2 isoform and HK II in
these cells (Figure 6C). We next addressed whether VDAC1/3
2/2
cells were protected from the noxious activity of the TAT-HK
peptide. To our surprise, VDAC1/3
2/2 MEFs were highly
sensitive to the peptide (Figure 6D) in a concentration-dependent
manner (data not shown). We also found that cell death was
inhibited by Debio 025, by the pan-caspase inhibitor Z.VAD-fmk
and by bongkrekate (Figure 6D). These observations support a
model in which HK II displacement from mitochondria triggers a
PTP-dependent but VDAC-independent apoptotic cascade. This
model is strongly supported by direct measurements of pore
opening in VDAC1/3
2/2 MEFs treated with TAT-HK, where
the peptide induced a fast mitochondrial depolarization that was
abrogated by Debio 025 (Figure 6E).
Discussion
Mitochondrial HK II integrates information from growth
factor signalling, and acts as a powerful anti-apoptotic
gatekeeper to suppress cell death in conditions of adequate
nutrition. This is of pivotal importance in cancer, because
neoplastic cells display an aberrant hyper-activation of growth
Figure 5. ANT modulates apoptosis triggered by detachment of HK II from mitochondria. (A) Western blot of ANT immunoprecipitation.
Co-immunoprecipitation of CyP-D in wild-type mouse fibroblasts is shown either in control conditions or after a 1 hour treatment with TAT-HK. (B)
Output of multiparametric FACS analyses show apoptosis induction in fibroblasts obtained either from wild-type mice (upper row) or from CyP-D
knock-out animals (lower row). Cells were exposed for 2 hours to the stated concentrations of TAT-HK with or without a 3 hour pre-incubation with
bongkrekate (BK, 100 mM). Diagrams and percentages of the different cell populations are indicated as in Fig. 1B. All reported measures in the Figure
are representative of at least four experiments.
doi:10.1371/journal.pone.0001852.g005
HK Release from Mitochondria
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and activation of HK II on mitochondria confers a competitive
edge to the most aggressive cancers by increasing their glycolytic
metabolism [3], and thus supporting cell proliferation when the
tumour mass outgrows the surrounding blood vessels [2]. It is
therefore crucial for anti-neoplastic strategies to dissect in detail
the mechanisms by which HK II controls the death/survival
rheostat of cells.
In this report, we have confirmed that HK II dissociation from
mitochondria is a strong pro-apoptotic stimulus, and established
Figure 6. Neither insulin nor VDAC modulate apoptosis triggered by detachment of HK II from mitochondria. (A) After 10 minutes of
insulin (5 mg/ml) stimulation, HeLa cells were exposed for 2 hours to the reported concentrations of TAT-HK and apoptosis assayed as in Figure 1B.
Western immunoblot shows GSK3b inhibition (i.e. Ser9 phosphorylation) by insulin. (B) HK II and VDAC expression in MEF obtained from either wild-
type or VDAC 1/3 knock-out mice were assessed by Western immunoblot. VDAC expression was checked with an anti-VDAC1antibody, protein
loading with an anti-actin antibody. (C) Immunoprecipitation of HK II and rehybridization with an anti VDAC2 in VDAC1/3 knock-out MEFs. (D) Output
of multiparametric FACS analyses show apoptosis induction in VDAC1/3 knock-out MEFs. Cells were exposed for 1 hour to the stated concentrations
of TAT-HK with or without pre-incubation with Debio 025 (DB, 8 mM), bongkrekate (BK, 100 mM) or Z.VAD-fmk (50 mM). Diagrams and percentages of
the different cell populations are indicated as in Fig. 1B. (E) Mitochondrial depolarization after cell treatment with TAT-HK (10 mM) with or without
pre-incubation with Debio 025 (8 mM), as assessed by decreased TMRM staining by epifluorescence microscopy. All reported measurements are
representative of at least four experiments.
doi:10.1371/journal.pone.0001852.g006
HK Release from Mitochondria
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PTP independently of VDAC. This observation has conceptual
and therapeutical implications. Loss of mitochondrial membrane
integrity constitutes a point of no-return in cell commitment to
death. Critical effector mechanisms include loss of ATP produc-
tion and the eventual release from the mitochondrial intermem-
brane space of proteins with key functions in cell dismantling. The
size of these proteins entails specific forms of OMM permeabiliza-
tion for their release, whose molecular mechanisms remain
controversial. One possibility is the direct formation of large
channels on the OMM, composed either by proapoptotic Bcl-2
family proteins, or by association of these proteins with
mitochondrial membrane channels; proteins might also be
funnelled through lipidic pores. Alternatively, opening of the
PTP in the IMM could indirectly induce ruptures in the OMM
that are large enough to allow release of apoptogenic protein
(reviewed in 16,34). The two mechanisms are not mutually
exclusive. For instance, cristae remodelling could be required as a
PTP-dependent first step to trigger channel opening on the OMM
[35]; and differences in the mode of OMM permeabilization could
depend on the cell type, the stress stimulus and the energetic
conditions of the cell.
Our data indicate that HK release from the OMM prompts a
death stimulus that requires PTP opening. The detailed mecha-
nism cannot be defined at present, as the molecular composition of
the PTP remains an unsolved riddle. In fact, all suspected pore
components, i.e. CyP-D, VDAC and ANT, underwent a rigorous
analysis based on the ablation of their coding genes followed by
investigation of PTP properties, and none of them turned out to be
part of the pore, even if ANT and CyP-D are PTP regulators [18–
22,32,36]. Here, we found that both ANT and CyP-D are key
regulators of apoptosis induced by mitochondrial HK II
displacement. Treatment with the TAT-HK peptide disrupts the
interaction between ANT and CyP-D, suggesting that HK II
partitioning away from mitochondria propagates a conformational
change directed from molecules associated to the OMM towards
structures of the inner membrane, where the PTP resides [15].
This might trigger PTP opening, resulting in the release of
apoptogenic proteins and in cell death.
Our results challenge the view that VDAC is the mitochon-
drial determinant of cell survival or death, acting as a hub that
binds either anti- or pro-apoptotic Bcl-2 family members
depending on the presence or absence of HK II, respectively
[2]. This model did not explain how HK dissociation from
mitochondria could induce OMM permeabilization even in the
absence of Bax and Bak [4]. Here we demonstrate that HK II/
VDAC binding is also disrupted in conditions that do not
promote cell death, i.e. following treatment with Debio 025.
More importantly, in cells lacking both VDAC1 and VDAC3,
no binding between HK II and the residual VDAC2 could be
detected, yet displacement of HK II from mitochondria
prompted massive cell death. In addition, the interaction
between VDAC and HK II was reported to be inhibited by
GSK3b-mediated VDAC phosphorylation, and stimulated by
Akt-dependent inactivation of GSK3b [11], and this would
protect from cell death. However, we found that treating cells
with insulin, a powerful Akt activator, cells were not protected
from apoptosis elicited by mitochondrial HK II displacement.
Again, these results argue against a mandatory cell survival role
of a transduction pathway that should convey signals to VDAC.
Thus, VDAC appears to be dispensable for cell death elicited by
HK II detachment from mitochondria, while resistance to cell
death in highly glycolytic tumors appears to be critically
dependent on preventing opening of the mitochondrial PTP.
Materials and Methods
Chemicals, antibodies and cells
FITC-conjugated Annexin-V was from Boehringer Mannheim
(Indianapolis, IN); Calcium Green-5N and tetramethylrhodamine
methyl ester (TMRM) were from Molecular Probes (Eugene, OR);
the caspase inhibitor Z.VAD-fluoro-methyl-ketone (Z.VAD-fmk)
was from Bachem (Subendorf, Switzerland); all other chemicals
were from Sigma (St. Louis, MO). Debio 025 was a generous gift
of Debiopharm (Lausanne, Switzerland). The mouse monoclonal
anti-prohibitin antibody was from Lab Vision (Fremont, CA); the
mouse monoclonal anti-actin antibody was from Sigma; the
monoclonal anti-CyP-D antibody was from Calbiochem (San
Diego, CA); the rabbit polyclonal anti VDAC1 antibody was from
Abcam, (Cambridge, UK); the goat polyclonal anti HK II, anti
VDAC2 and anti ANT antibodies and the mouse monoclonal anti
GSK-3 antibody were from Santa Cruz Biotechnology (Santa
Cruz, CA); the mouse monoclonal anti-cytochrome c antibody was
from Becton Dickinson Pharmingen (Franklin Lakes, NJ); the
rabbit monoclonal anti Bcl-XL and anti phospho Ser-GSK-3
antibodies were from Cell Signaling (Beverly, MA). Diaphragm
adult fibroblasts were obtained by SV40 immortalization of
primary cells from wild-type and Ppif
2/2 mice; mouse embryo
fibroblasts (MEF) from wild-type and VDAC1/3
2/2 mice were
obtained as described [37]. Apoptosis inducers were added to
exponentially growing cells in the absence of serum. Chemical
inhibitors of caspases, CyP-D or ANT were added three hours
before starting apoptosis induction. As in the following, each
experiment was repeated at least four times.
Flow cytometry analysis of apoptosis induction
Flow cytometry recordings of apoptotic changes were performed
as described [38,39]. Briefly, after induction of apoptosis, cells were
resuspended in 135 mM NaCl, 10 mM HEPES, 5 mM CaCl2 and
incubated for 15 min at 37uC in FITC-conjugated Annexin-V,
TMRM (200 nM) and propidium iodide (PI, 1 mg/ml), to detect
mitochondrial depolarization (reduced TMRM staining), phospha-
tidylserine exposure on the cell surface (increased FITC-conjugated
Annexin-V staining), and loss of plasma membrane integrity (PI
permeability and staining). Samples were analyzed on a FACSCa-
libur flow cytometer (Becton Dickinson, San Diego, CA, USA).
Data acquisition was performed using CellQuest software and data
analysis with WinMDI software. Each experiment was repeated at
least four times, and consistency of data allowed to show one
representative experiment for each condition.
Isolation of mouse mitochondria
Mitochondria were isolated from livers and muscles of wild-type
and Ppif
2/2 C57BL/6 mice [19] through sequential centrifuga-
tions, as described [40]. All procedures were carried out at 0–4uC.
Measurement of mitochondrial Ca
2+ retention capacity
The Ca
2+ retention capacity (CRC) assay was used to assess
PTP opening following trains of Ca
2+ pulses [40] and measured
fluorimetrically at 25uC in the presence of the Ca
2+ indicator
Calcium Green-5N (1 mM; lexc: 505 nm; lem: 535 nm; Molecular
Probes). We performed CRC experiments either on isolated
mitochondria or on whole cells placed in an isotonic buffer
(130 mM KCl, 1 mM Pi-Tris, 10 mM Tris/MOPS, 1 mM
EGTA/Tris, pH 7.4) in the presence of 2 mM rotenone/5 mM
succinate or 250 mM glutamate/125 mM malate and of 10 mM
cytochrome c. Whole cell CRC was carried out after plasma
membrane permeabilization with the non-ionic detergent digito-
nin, which is highly selective for cholesterol-enriched membranes
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washed twice in a buffer composed of 130 mM KCl, 10 mM Tris/
MOPS, 1 mM Pi-Tris, 1 mM EGTA/Tris, pH 7.4, and then
incubated with 50–150 mM digitonin (depending on the cell type)
for 15 min at 4uC. Digitonin was then washed away by spinning
cells twice in a cytosolic-like solution (130 mM KCl, 10 mM Tris/
MOPS, 1 mM Pi-Tris, 0.1 mM EGTA/Tris, pH 7.4), and the
number of cells carefully assessed before starting each experiment.
Mitochondrial respiration assay
Mitochondrial oxygen consumption was measured polaro-
graphically at 25uC with a Clark oxygen electrode (Yellow Springs
Instruments, OH, USA). Mitochondria were incubated in a
solution of 130 mM KCl, 10 mM Tris-Mops, 1 mM Pi-Tris,
20 mM EGTA-Tris and 250 mM glutamate/125 mM malate or
2 mM rotenone/5 mM succinate to assay basal respiration (state
4). ADP (200 mM) was subsequently added to measure state 3
respiration, followed by the uncoupling agent dinitrophenol (DNP,
100 mM) to assess the maximal respiration rate.
Cell lysis, fractionation and Western immunoblot analysis
Total cell extracts were prepared at 4uC in 135 mM NaCl,
20 mM Tris-HCl pH 7.5, 1 mM CaCl2, 1% NP40 or 1% Triton
X-100 in the presence of phosphatase and protease inhibitors. To
prepare mitochondrial extracts, cells were placed cells in a
hypotonic solution (10 mM Tris-HCl pH 7.6, 10 mM KCl,
150 mM MgCl2) and homogenized at 4uC. Mitochondria were
then isolated by differential centrifugation. For immunoprecipita-
tions, 1000–1500 mg of proteins per reaction were incubated with
antibodies conjugated to protein A- or protein G-Sepharose beads
(Pharmacia, Pfizer, Cambridge, MA) at 4uC overnight. Negative
controls were performed by incubating lysates on conjugated
beads in the absence of primary antibodies. Samples were then
separated in reducing conditions on SDS-polyacrylamide gels and
transferred onto Hybond-C Extra membranes (Amersham, Little
Chalfont, UK). Primary antibodies were incubated 16 hours at
4uC, and horseradish peroxidase-conjugated secondary antibodies
were added for 1 hour. Proteins were visualized by enhanced
chemiluminescence (Amersham).
Peptide synthesis
Peptides MIASHLLAYFFTELNbA-GYGRKKRRQRRRG
(TAT-HK) and GYGRKKRRQRRRG-bA-EEEAKNAAAKLA-
VEILNKEKK (TAT-Ctr) were synthesized by a solid phase
method using an automatized peptide synthesizer (model 431-A,
Applied Biosystems, Foster City, CA). The fluoren-9-ylmethox-
ycarbonyl (Fmoc) strategy [41] was used throughout the peptide
chain assembly, utilizing 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetra-
methyluronium hexafluorophosphate (HBTU) and 1-hydroxyben-
zotriazole (HOBt) as coupling reagents. HMPA PEGA resin
(Novabiochem, Bad Soden, Germany) was used as solid support.
The side-chain protected amino acid building blocks used
were: Fmoc-Tyr(tert-butyl), Fmoc-Glu(tert-butyl), Fmoc-Ser(tert-
butyl), Fmoc-Thr(tert-butyl), Fmoc-Lys(tert-butyloxycarbonyl),
Fmoc-His(trityl), Fmoc-Asn(trityl), Fmoc-Gln(trityl), and Fmoc-
Arg(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl). Cleav-
age of the peptides was performed by reacting the peptidyl-resins
with a mixture containing TFA/H20/thioanisole/ethanedithiol/
phenol (10 ml/0.5 ml/0.5 ml/0.25 ml/750 mg) for 2.5 h. Crude
peptides were purified by a preparative reverse phase HPLC.
Molecular masses of the peptides were confirmed by mass
spectroscopy with direct infusion on a Micromass ZMD-4000
Mass Spectrometer (Waters-Micromass). The purity of the
peptides was about 95% as evaluated by analytical reverse phase
HPLC.
Mitochondrial membrane potential assay
This was measured in the presence of 20 nM TMRM as
described elsewhere [24, 42]. Fluorescent images were acquired
with an Olympus (Center Valley, PA) IX71/IX51 inverted
microscope equipped with a xenon light source and with a 12-
bit digital cooled charge-coupled device (CCD) camera (Micro-
max, Princeton Instruments, Trenton, NJ). For detection of
fluorescence, 568 6 25-nm bandpass excitation and 585-nm
longpass emission filter settings were used. Images were collected
with an exposure time of 100 msec. Data were acquired and
analyzed by using Cell
R software (Olympus). Clusters of 10–30
mitochondria were acquired every 2 min, and fields not
containing cells were taken as the background.
Determination of mitochondrial permeability transition
(MPT) ROS threshold (tMPT)
Cardiac myocyte isolation, confocal microscopy and determi-
nation of MPT ROS threshold have been described [12, 29].
Briefly, isolated myocytes loaded with 125 nM TMRM were
exposed in vitro to conditions that mimic oxidative stress by
repetitive laser line-scanning of a row of ,25 mitochondria at
2 Hz with an LSM-510 confocal microscope (Carl Zeiss Inc., Jena,
Germany) with excitation at 543nm and collecting emission at
.560 nm using a 63x/1.4 oil immersion objective. This results in
controlled, incremental photodynamic production of ROS in the
scanned area with consequent MPT induction. MetaMorph image
analysis software (Molecular Devices Corp., Downingtown PA)
was used to calculate tMPT and was defined as average time
required to induce MPT in targeted mitochondria.
Acknowledgments
We thank Davide Bartoli for technical assistance, Luca Scorrano for
providing the immortalized CyP-D knock-out fibroblasts, William J.
Craigen for providing the immortalized VDAC knock-out fibroblasts and
Debiopharm SA, Lausanne, for the gift of Debio 025.
Author Contributions
Conceived and designed the experiments: SS PB AR FC MJ. Performed
the experiments: SS FC DC WB MJ. Analyzed the data: MF AR FC VP
WB. Contributed reagents/materials/analysis tools: OM. Wrote the paper:
PB AR.
References
1. Wilson JE (2003) Isozymes of mammalian hexokinase: structure, subcellular
localization and metabolic function. J Exp Biol 206: 2049–2057.
2. Mathupala SP, Ko YH, Pedersen PL (2006) Hexokinase II: cancer’s double-
edged sword acting as both facilitator and gatekeeper of malignancy when
bound to mitochondria. Oncogene 25: 4777–4786.
3. Warburg O (1956) On the origin of cancer cells. Science 123: 309–314.
4. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, et al. (2004)
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit
apoptosis in the presence or absence of Bax and Bak. Mol Cell 16: 819–830.
5. Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, et al. (2003) Akt-
directed glucose metabolism can prevent Bax conformation change and promote
growth factor-independent survival. Mol Cell Biol 23: 7315–7328.
6. Pastorino JG, Hoek JB (2003) Hexokinase II: the integration of energy
metabolism and control of apoptosis. Curr Med Chem 10: 1535–1551.
7. Vyssokikh M, Brdiczka D (2004) VDAC and peripheral channelling complexes
in health and disease. Mol Cell Biochem 256–257: 117–126.
8. Colombini M (2004) VDAC: the channel at the interface between mitochondria
and the cytosol. Mol Cell Biochem 256–257: 107–115.
HK Release from Mitochondria
PLoS ONE | www.plosone.org 10 March 2008 | Volume 3 | Issue 3 | e18529. Shoshan-Barmatz V, Israelson A, Brdiczka D, Sheu SS (2006) The voltage-
dependent anion channel (VDAC): function in intracellular signalling, cell life
and cell death. Curr Pharm Des 12: 2249–2270.
10. Zaid H, Abu-Hamad S, Israelson A, Nathan I, Shoshan-Barmatz V (2005) The
voltage-dependent anion channel-1 modulates apoptotic cell death. Cell Death
Differ 12: 751–760.
11. Pastorino JG, Hoek JB, Shulga N (2005) Activation of glycogen synthase kinase
3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating
voltage-dependent anion channel and potentiates chemotherapy-induced
cytotoxicity. Cancer Res 65: 10545–10554.
12. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, et al. (2004) Glycogen
synthase kinase-3beta mediates convergence of protection signaling to inhibit the
mitochondrial permeability transition pore. J Clin Invest 113: 1535–1549.
13. Zhou H, Hou Q, Chai Y, Hsu YT (2005) Distinct domains of Bcl-XL are
involved in Bax and Bad antagonism and in apoptosis inhibition. Exp Cell Res
309: 316–328.
14. Pastorino JG, Shulga N, Hoek JB (2002) Mitochondrial binding of hexokinase II
inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 277:
7610–7618.
15. Bernardi P, Krauskopf A, Basso E, Petronilli V, Blachly-Dyson E, et al. (2006)
The mitochondrial permeability transition from in vitro artifact to disease target.
Febs J 273: 2077–2099.
16. Rasola A, Bernardi P (2007) The mitochondrial permeability transition pore and
its involvement in cell death and in disease pathogenesis. Apoptosis 12: 815–833.
17. Machida K, Ohta Y, Osada H (2006) Suppression of apoptosis by cyclophilin D
via stabilization of hexokinase II mitochondrial binding in cancer cells. J Biol
Chem 281: 14314–14320.
18. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, et al. (2005) Loss of
cyclophilin D reveals a critical role for mitochondrial permeability transition in
cell death. Nature 434: 658–662.
19. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, et al. (2005) Properties of
the permeability transition pore in mitochondria devoid of cyclophilin D. J Biol
Chem 280: 18558–18561.
20. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, et al. (2005)
Cyclophilin D-dependent mitochondrial permeability transition regulates some
necrotic but not apoptotic cell death. Nature 434: 652–658.
21. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, et al. (2005)
Cyclophilin D is a component of mitochondrial permeability transition and
mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad
Sci U S A 102: 12005–12010.
22. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, et al. (2004) The ADP/
ATP translocator is not essential for the mitochondrial permeability transition
pore. Nature 427: 461–465.
23. Hansson MJ, Mattiasson G, Mansson R, Karlsson J, Keep MF, et al. (2004) The
nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display
nanomolar potencies on permeability transition in brain-derived mitochondria.
J Bioenerg Biomembr 36: 407–413.
24. Angelin A, Tiepolo T, Sabatelli P, Grumati P, Bergamin N, et al. (2007)
Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular
dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci U S A
104: 991–996.
25. Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V (2004) In
self-defence: hexokinase promotes voltage-dependent anion channel closure
and prevents mitochondria-mediated apoptotic cell death. Biochem J 377:
347–355.
26. Robey RB, Hay N (2006) Mitochondrial hexokinases, novel mediators of the
antiapoptotic effects of growth factors and Akt. Oncogene 25: 4683–4696.
27. Juhaszova M, Wang S, Zorov B, Nuss H, Gleichmann M, et al. (2008) The
identity and regulation of the mitochondrial permeability transition pore: Where
the known meets the unknown. Ann N Y Acad Sci. (in press).
28. Postic C, Leturque A, Printz RL, Maulard P, Loizeau M, et al. (1994)
Development and regulation of glucose transporter and hexokinase expression in
rat. Am J Physiol 266: E548–559.
29. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ (2000) Reactive oxygen
species (ROS)-induced ROS release: a new phenomenon accompanying
induction of the mitochondrial permeability transition in cardiac myocytes.
J Exp Med 192: 1001–1014.
30. Halestrap AP, Kerr PM, Javadov S, Woodfield KY (1998) Elucidating the
molecular mechanism of the permeability transition pore and its role in
reperfusion injury of the heart. Biochim Biophys Acta 1366: 79–94.
31. Belzacq AS, Vieira HL, Kroemer G, Brenner C (2002) The adenine nucleotide
translocator in apoptosis. Biochimie 84: 167–176.
32. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD (2007) Voltage-
dependent anion channels are dispensable for mitochondrial-dependent cell
death. Nat Cell Biol 9: 550–555.
33. Blachly-Dyson E, Zambronicz EB, Yu WH, Adams V, McCabe ER, et al. (1993)
Cloning and functional expression in yeast of two human isoforms of the outer
mitochondrial membrane channel, the voltage-dependent anion channel. J Biol
Chem 268: 1835–1841.
34. Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the
calcium-apoptosis link. Nat Rev Mol Cell Biol 4: 552–565.
35. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, et al. (2002) A distinct
pathway remodels mitochondrial cristae and mobilizes cytochrome c during
apoptosis. Dev Cell 2: 55–67.
36. Krauskopf A, Eriksson O, Craigen WJ, Forte MA, Bernardi P (2006) Properties
of the permeability transition in VDAC1
-/- mitochondria. Biochim Biophys Acta
1757: 590–595.
37. Wu S, Sampson MJ, Decker WK, Craigen WJ (1999) Each mammalian
mitochondrial outer membrane porin protein is dispensable: effects on cellular
respiration. Biochim Biophys Acta 1452: 68–78.
38. Gramaglia D, Gentile A, Battaglia M, Ranzato L, Petronilli V, et al. (2004)
Apoptosis to necrosis switching downstream of apoptosome formation requires
inhibition of both glycolysis and oxidative phosphorylation in a BCL-XL-a n d
PKB/AKT-independent fashion. Cell Death Differ 11: 342–353.
39. Rasola A, Geuna M (2001) A flow cytometry assay simultaneously detects
independent apoptotic parameters. Cytometry 45: 151–157.
40. Fontaine E, Eriksson O, Ichas F, Bernardi P (1998) Regulation of the
permeability transition pore in skeletal muscle mitochondria. Modulation By
electron flow through the respiratory chain complex I. J Biol Chem 273:
12662–12668.
41. Fields GB, Noble RL (1990) Solid phase peptide synthesis utilizing 9-
fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 35: 161–214.
42. Petronilli V, Penzo D, Scorrano L, Bernardi P, Di Lisa F (2001) The
mitochondrial permeability transition, release of cytochrome c and cell death.
Correlation with the duration of pore openings in situ. J Biol Chem 276:
12030–12034.
HK Release from Mitochondria
PLoS ONE | www.plosone.org 11 March 2008 | Volume 3 | Issue 3 | e1852